RAPID DISPATCH
24/H dispatch
2 in stock
PROFHILO® STRUCTURA is an injectable medical treatment for the face, aimed at restoring and strengthening subcutaneous fat tissue. Thanks to the high and low molecular weight hyaluronic acid cooperative hybrid complexes (HCCs), thermally stabilised without chemical agents such as BDDE, the product promotes a natural lifting effect, improving tone, facial contour and skin quality. NAHYCO® technology ensures high biocompatibility and increased resistance to enzymatic degradation.
USE MEDICAL STRICT. Medical device. Injection of hyaluronic acid. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
PROFHILO® STRUCTURA is a sterile gel:
- Composed of a high concentration of HA (90mg/2ml) that guarantees ease and safety during injection.
- Composed of a natural, heat-stabilised HA without BDDE or other chemicals, with improved resistance to enzymatic degradation.
- Excellent biocompatibility and tolerance due to the absence of chemical modifications.
- NAHYCO® TECHNOLOGY.
- IBSA FARMACEUTICI ITALIA S.R.L.
- NAME: PROFHILO® STRUCTURA
- COMPOSITION: 45 mg HA high and 45 g HA low per 2 ml - total 90 mg HA.
- PRESENTATION: 1 x 2mL.
- NEEDLES: 1 x TSK(21Gx25mm), 1 x TSK(23Gx19mm)
- CANNAS: 1 x TSK(22Gx50mm), 1 x TSK(25Gx38mm).
- INDICATIONS: Ageing occurs as a result of the interaction of changes in the skeleton, ligaments, muscles, adipose tissue and facial skin. The characteristic signs of facial skin ageing are partly associated with age-related changes in the subcutaneous fat tissue. Due to the effect of gravity, the movement of fat within the compartments can cause an inferomedial displacement of the overlying skin envelope. The result of this repositioning or displacement of fat are often more hollow cheeks and a flattening of the facial angles. As a result, there is a loss of fat volume in the middle and lateral cheek compartments.
- INJECTION DEPTH: in the superficial adipose compartment.
- DURATION: approximately 4-6 months. The duration of the effect may vary depending on various individual factors, including age, lifestyle, skin quality and individual response to treatment.
- USE: Strict medical use.
- Syringes: 1 x 2mL.
- Each box contains one pre-filled, single-use, sterile 2mL syringe of PROFHILO® STRUCTURA, two needles: 1 x TSK(21Gx25mm), 1 x TSK(23Gx19mm), two cannulae: 1 x TSK(22Gx50mm), 1 x TSK(25Gx38mm), instructions for use and two implant cards.
PROFHILO® STRUCTURA focuses on more specific structural improvements of the face. This treatment deepens the repair and strengthening of subcutaneous fat tissue, giving a more defined and lifted effect. PROFHILO® STRUCTURA is particularly effective for patients who desire not only an improvement in skin quality, but also a more visible lifting and improvement in the contour of certain areas of the face.
- Hyaluronic acid, sodium hyaluronate, sodium chloride, sodium phosphate and water for injectable preparations.
- 45 mg high HA and 45 g low HA per 2 ml - total 90 mg HA.
- Exclusive use by healthcare professionals: The treatment must only be administered by qualified healthcare professionals.
- Do not administer the product in areas with active infection or inflammation.
- Consult your doctor before use in patients with pre-existing dermatological conditions.
- Do not mix PROFHILO® STRUCTURA with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form.
- Pregnancy and lactation: The treatment is not indicated for use during pregnancy or lactation.
- Auto-immune diseases: contraindicated in case of autoimmune diseases.
- Do not administer the product in areas with active infection or inflammation.
- Avoid use in case of known hypersensitivity or allergy to any of the components of the product.
Repair and strengthening of subcutaneous fat tissue. Improvement of skin quality, more visible lifting and improvement of the contour of certain facial areas.
It restores and strengthens the subcutaneous fat tissue, improves the facial contour, gives a lifted effect and increases skin firmness.
It focuses on the cheeks, middle and lateral areas of the face, with improvement in the definition of facial angles and overall structure.
It is composed of high and low molecular weight hyaluronic acid cooperative hybrid complexes (HCCs), thermally stabilised without the use of chemical agents such as BDDE, for enhanced biocompatibility.
The product is injected into the superficial adipose compartment using specific needles or cannulae, following medical protocols customised to the patient's needs.
The average treatment effects last about 4-6 months, varying according to age, lifestyle, skin quality and individual response.